8 January 2025
The following is an update to the fourth quarter 2024 outlook and gives an overview of our current expectations for the fourth quarter. Outlooks…
7 January 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma GSK plc (LSE/NYSE: GSK) announced today that…
GlobalData Plc Acquisition Updates Healthcare Division: Acquisition of Deallus GlobalData Plc (‘GlobalData’ or the ‘Group’), a leading data, analytics, and insights platform, today announces further progress…
24 December 2024
Harworth Group plc (“Harworth” or “the Group”) Completion of sale of Ansty Strategic Land site for £53.5 million Harworth Group plc, a leading regenerator…
M.P. EVANS GROUP PLC (“Group” or “M.P. Evans”) Extension of share buyback programme The board of directors of M.P. Evans (the “Board”) is pleased…
19 December 2024
GlobalData Plc Financing Update New £340m debt financing facilities GlobalData Plc (‘GlobalData’ or the ‘Group’), a leading data, analytics, and insights platform, today announces new Financing…
Agreement to acquire 100% of Stonebridge Homes Outstanding 50% stake to be acquired from JV partner in a three tranche structure over five years…
17 December 2024
17 December 2024 BUNZL PRE-CLOSE STATEMENT Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its…